Evidence map›Paper›PMID 25848867›Full record

ArticleNature immunology2015

Let-7 microRNAs target the lineage-specific transcription factor PLZF to regulate terminal NKT cell differentiation and effector function.

Leonid A Pobezinsky, Ruth Etzensperger, Susanna Jeurling, Amala Alag, Tejas Kadakia, Tom M McCaughtry, Motoko Y Kimura, Susan O Sharrow, Terry I Guinter, Lionel Feigenbaum and 1 more

Open access · greenAbstract read
In one paragraph

Article in Nature immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 94 papers.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

94 citing papers in PubMed, 151 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Let-7 Family as a Mediator of Exercise on Alzheimer's Disease.Cellular and molecular neurobiology · 2025
    Review
  6. Regulation of HSC development and function by Lin28b.Frontiers in cell and developmental biology · 2025
    Review
  7. Review
  8. Article
  9. Article
  10. Downregulation ofeLife · 2024
    Article
  11. Article
  12. Downregulation ofbioRxiv : the preprint server for biology · 2024
    Article
  13. Article
  14. Article
  15. TET proteins regulateFrontiers in immunology · 2024
    Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Leonid A PobezinskyExperimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Ruth EtzenspergerExperimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Susanna JeurlingExperimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Amala AlagExperimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Tejas KadakiaExperimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Tom M McCaughtryExperimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Motoko Y KimuraExperimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Susan O SharrowExperimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Terry I GuinterExperimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Lionel FeigenbaumSAIC-Frederick, NCI-Frederick Cancer Research and Development Center, Frederick, Maryland, USA.
Alfred SingerExperimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
National Cancer Institute · USNational Institutes of Health · USScience Applications International Corporation (United States) · US

Funding

T Cell Differentiation and Repertoire SelectionZIABC009273 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI SINGER, ALFRED · 2009 to 2025
$11.6M
Development and function of regulatory T cellsZIABC011112 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI SINGER, ALFRED · 2009 to 2025
$6.8M
Cytokine signaling in developing thymocytes and T cellsZIABC011111 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI SINGER, ALFRED · 2009 to 2023
$4.8M
Specification of T cell function during developmentZIABC011106 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI SINGER, ALFRED · 2009 to 2023
$4.8M
T cell survivalZIABC011113 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI SINGER, ALFRED · 2009 to 2023
$4.8M
Role of microRNAs in T cell developmentZIABC011114 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI SINGER, ALFRED · 2009 to 2023
$4.8M
T cell receptor regulation of cytokine signalingZIABC011117 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI SINGER, ALFRED · 2009 to 2023
$4.8M
Intramural NIH HHS ZIA BC011114
6 · The paper itself

Abstract

Lethal-7 (let-7) microRNAs (miRNAs) are the most abundant miRNAs in the genome, but their role in developing thymocytes is unclear. We found that let-7 miRNAs targeted Zbtb16 mRNA, which encodes the lineage-specific transcription factor PLZF, to post-transcriptionally regulate PLZF expression and thereby the effector functions of natural killer T cells (NKT cells). Dynamic upregulation of let-7 miRNAs during the development of NKT thymocytes downregulated PLZF expression and directed their terminal differentiation into interferon-γ (IFN-γ)-producing NKT1 cells. Without upregulation of let-7 miRNAs, NKT thymocytes maintained high PLZF expression and terminally differentiated into interleukin 4 (IL-4)-producing NKT2 cells or IL-17-producing NKT17 cells. Upregulation of let-7 miRNAs in developing NKT thymocytes was signaled by IL-15, vitamin D and retinoic acid. Such targeting of a lineage-specific transcription factor by miRNA represents a previously unknown level of developmental regulation in the thymus.

Indexed as

AnimalsCell DifferentiationCell LineageCytokinesCytotoxicity, ImmunologicKruppel-Like Transcription FactorsMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicMicroRNAsNatural Killer T-CellsPromyelocytic Leukemia Zinc Finger ProteinProtein BindingRNA Processing, Post-TranscriptionalThymocytesCytokinesKruppel-Like Transcription FactorsMicroRNAsmirnlet7 microRNA, mousePromyelocytic Leukemia Zinc Finger ProteinTretinoinVitamin DZbtb16 protein, mouse

Identifiers

PMID25848867
PMCPMC4406853
OpenAlexW2032760411

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.